Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

European Epidemiologic COHORT Study: A Prospective Epidemiologic COHORT Study Of Ocular Safety In Patients Receiving Macugen Injections For Neovascular Age-Related Macular Degeneration (AMD) In Europe

NCT00460408 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00460408
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00460408 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
European Epidemiologic COHORT Study: A Prospective Epidemiologic COHORT Study Of Ocular Safety In Patients Receiving Macugen Injections For Neovascular Age-Related Macular Degeneration (AMD) In Europe
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
August 31, 2006
Completion date
February 29, 2012
Enrollment
501 (actual)
Sites
68

Conditions

As the registry lists them; a condition with its own page is linked.

macular degeneration